Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3

Mohsen Ghadami, Yoshio Makita, Kunihiro Yoshida, Gen Nishimura, Yoshimitsu Fukushima, Keiko Wakui, Shiro Ikegawa, Koki Yamada, Shinji Kondo, Norio Niikawa, Hiro Aki Tomita

Research output: Contribution to journalArticlepeer-review

66 Citations (Scopus)


Camurati-Engelmann disease (CED [MIM 131300]), or progressive diaphyseal dysplasia, is an autosomal dominant sclerosing bone dysplasia characterized by progressive bone formation along the periosteal and endosteal surfaces at the diaphyseal and metaphyseal regions of long bones and cranial hyperostosis, particularly at the skull base. The gene for CED, or its chromosomal localization, has not yet been identified. We performed a genomewide linkage analysis of two unrelated Japanese families with CED, in which a total of 27 members were available for this study; 16 of them were affected with the disease. Two-point linkage analysis revealed a maximum LOD score of 7.41 (recombination fraction .00; penetrance 1.00) for the D19S918 microsatellite marker locus. Haplotype analysis revealed that all the affected individuals shared a common haplotype observed, in each family, between D19S881 and D19S606, at chromosome 19q13.1-q13.3. These findings, together with a genetic distance among the marker loci, indicate that the CED locus can be assigned to a 15.1-cM segment between D19S881 and D19S606.

Original languageEnglish
Pages (from-to)143-147
Number of pages5
JournalAmerican Journal of Human Genetics
Issue number1
Publication statusPublished - 2000


Dive into the research topics of 'Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3'. Together they form a unique fingerprint.

Cite this